Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Tarih
2017
Yazar
Yazici, H.
Esatoglu, S. N.
Hamuryudan, V.
Hatemi, G.
Ucar, Didar
Ozyazgan, Y.
Yurdakul, S.
Seyahi, E.
Guzelant, G.
Üst veri
Tüm öğe kaydını göster
Özet
Objective. The prognosis of uveitis in Behcet's syndrome (BS) has improved over decades. Whether this is related to the use of more aggressive management strategies is not known.
Bağlantı
http://hdl.handle.net/20.500.12627/88285
Koleksiyonlar